The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?

Eur J Prev Cardiol. 2016 Jul;23(10):1062-4. doi: 10.1177/2047487315600818. Epub 2015 Aug 12.

Authors

Amit V Khera¹, Pradeep Natarajan², Sekar Kathiresan²

Affiliations

¹ Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital, Boston, USA avkhera@mgh.harvard.edu.
² Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital, Boston, USA.

No abstract available

MeSH terms

Cholesterol, HDL
Cholesterol, LDL
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy*

Substances

Cholesterol, HDL
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding

T32 HL007208/HL/NHLBI NIH HHS/United States